Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Amitriptyline
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{Short description|Tricyclic antidepressant}} {{Use American English|date=February 2024}} {{Use dmy dates|date=September 2024}} {{cs1 config|name-list-style=vanc|display-authors=6}} {{Infobox drug | Watchedfields = changed | verifiedrevid = 477169407 | image = Amitriptyline2DACS.svg | image_class = skin-invert-image | width = 200 | alt = | image2 = Amitriptyline-from-picrate-xtal-3D-balls.png | width2 = 250 | alt2 = | pronounce = {{IPAc-en|ˌ|æ|m|ᵻ|ˈ|t|ɹ|ɪ|p|t|ᵻ|l|iː|n}}<ref>{{cite web|url=https://www.lexico.com/en/definition/amitriptyline|archive-url=https://web.archive.org/web/20140714140116/http://www.oxforddictionaries.com/us/definition/english/amitriptyline?q=amitriptyline |url-status= dead |title=Amitriptyline |work= Oxford Dictionary |via= Lexico.com |archive-date=14 July 2014 | language= en |access-date=6 January 2021}}</ref> | tradename = Elavil, others | Drugs.com = {{drugs.com|monograph|amitriptyline-hydrochloride}} | MedlinePlus = a682388 | DailyMedID = Amitriptyline | pregnancy_AU = C | pregnancy_AU_comment =<ref name="Drugs.com pregnancy">{{cite web | title=Amitriptyline Use During Pregnancy | website=Drugs.com | date=2 September 2020 | url=https://www.drugs.com/pregnancy/amitriptyline.html | access-date=13 September 2020 | archive-date=9 November 2020 | archive-url=https://web.archive.org/web/20201109214320/https://www.drugs.com/pregnancy/amitriptyline.html | url-status=live }}</ref> | routes_of_administration = [[Oral administration|Oral]], [[intramuscular injection]] | class = [[Tricyclic antidepressant]] (TCA) | ATC_prefix = N06 | ATC_suffix = AA09 | legal_AU = S4 | legal_BR = C1 | legal_BR_comment = <ref>{{cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=31 March 2023 |title=RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |url-status=live |archive-url=https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |archive-date=3 August 2023 |access-date=16 August 2023 |publisher=[[Diário Oficial da União]] |language=pt-BR |publication-date=4 April 2023}}</ref> | legal_CA = Rx-only | legal_UK = POM | legal_US = Rx-only | bioavailability = 45%<ref name="pmid3893842"/>-53%<ref name = pmid33438398/> | protein_bound = 96%<ref name = TGA/> | metabolism = [[Liver]] (CYP2D6, CYP2C19, CYP3A4)<ref name="pmid15554244"/><ref name = pmid33438398/><ref name="pmid11583471"/> | metabolites = nortriptyline, (''E'')-10-hydroxynortriptyline | elimination_half-life = 21 hours<ref name="pmid3893842"/> | excretion = [[Urine]]: 12–80% after 48 hours;<ref name="pmid6667101"/> feces: not studied | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 50-48-6 | CAS_supplemental = <br />549-18-8 ([[hydrochloride]])<br />17086-03-2 ([[embonate]]) | PubChem = 2160 | IUPHAR_ligand = 200 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = DB00321 | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 2075 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = 1806D8D52K | KEGG_Ref = {{keggcite|correct|kegg}} | KEGG = D07448 | ChEBI_Ref = {{ebicite|correct|EBI}} | ChEBI = 2666 | ChEMBL_Ref = {{ebicite|correct|EBI}} | ChEMBL = 629 | synonyms = | IUPAC_name = 3-(10,11-dihydro-5''H''-dibenzo[''a'',''d'']cycloheptene-5-ylidene)-''N'',''N''-dimethylpropan-1-amine | C=20 | H=23 | N=1 | SMILES = c3cc2c(/C(c1c(cccc1)CC2)=C\CCN(C)C)cc3 | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = KRMDCWKBEZIMAB-UHFFFAOYSA-N | melting_point = 197.5 | melting_notes =<ref>{{cite journal |vauthors=Blessel KW, Rudy BC, Senkowski BZ |title=Amitriptyline Hydrochloride |journal=Analytical Profiles of Drug Substances |volume=3 |pages=127–148 |date=1974 |doi=10.1016/S0099-5428(08)60066-0|isbn=9780122608032 }}</ref><!-- all melting points for "amitriptyline" in the literature are for the hydrochloride salt --> }} '''Amitriptyline''', sold under the brand name '''Elavil''' among others, is a [[tricyclic antidepressant]] primarily used to treat [[major depressive disorder]], and a variety of pain syndromes such as [[neuropathic pain]], [[fibromyalgia]], [[migraine]] and [[tension headaches]].<ref name=EMC>{{cite web|title=Amitriptyline Tablets BP 50mg – Summary of Product Characteristics (SPC)|work=electronic Medicines Compendium|publisher=Actavis UK Ltd.|date=24 March 2013|access-date=1 December 2013|url=http://www.medicines.org.uk/emc/medicine/23738/SPC/Amitriptyline+Tablets+BP+50mg/|url-status=live|archive-url=https://web.archive.org/web/20131203015148/http://www.medicines.org.uk/emc/medicine/23738/SPC/Amitriptyline+Tablets+BP+50mg/|archive-date=3 December 2013}}</ref> Due to the frequency and prominence of side effects, amitriptyline is generally considered a [[Therapy#Lines of therapy|second-line therapy]] for these indications.<ref name=top100drugs/><ref name="pmid32040849"/><ref name="pmid27377815"/><ref name="pmid22529202"/> The most common side effects are dry mouth, drowsiness, dizziness, constipation, and weight gain. [[Glaucoma]], liver toxicity and [[arrhythmia|abnormal heart rhythms]] are rare but serious side effects. Blood levels of amitriptyline vary significantly from one person to another,<ref name="pmid28405886">{{cite journal | vauthors = Tfelt-Hansen P, Ågesen FN, Pavbro A, Tfelt-Hansen J | title = Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine | journal = CNS Drugs | volume = 31 | issue = 5 | pages = 389–403 | date = May 2017 | pmid = 28405886 | doi = 10.1007/s40263-017-0430-3 | s2cid = 23560743 }}</ref> and amitriptyline interacts with many other medications potentially aggravating its side effects. Amitriptyline was discovered in the late 1950s by scientists at [[Merck & Co.|Merck]] and approved by the US [[Food and Drug Administration]] (FDA) in 1961.<ref name="Half a century of antidepressant dr">{{cite journal | vauthors = Fangmann P, Assion HJ, Juckel G, González CA, López-Muñoz F | title = Half a century of antidepressant drugs: on the clinical introduction of monoamine oxidase inhibitors, tricyclics, and tetracyclics. Part II: tricyclics and tetracyclics | journal = Journal of Clinical Psychopharmacology | volume = 28 | issue = 1 | pages = 1–4 | date = February 2008 | pmid = 18204333 | doi = 10.1097/jcp.0b013e3181627b60 | s2cid = 31018835 }}</ref> It is on the [[WHO Model List of Essential Medicines|World Health Organization's List of Essential Medicines]].<ref name="WHO23rd">{{cite book | vauthors = ((World Health Organization)) | title = The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023) | year = 2023 | hdl = 10665/371090 | author-link = World Health Organization | publisher = World Health Organization | location = Geneva | id = WHO/MHP/HPS/EML/2023.02 | hdl-access=free }}</ref> It is available as a [[generic medication]].<ref name=AHFS2014>{{cite web| title= Amitriptyline Hydrochloride| url= https://www.drugs.com/monograph/amitriptyline-hydrochloride.html |publisher= The American Society of Health-System Pharmacists| website= Drugs.com| access-date=25 September 2014|url-status=live| archive-url= https://web.archive.org/web/20140924185142/http://www.drugs.com/monograph/amitriptyline-hydrochloride.html|archive-date=24 September 2014}}</ref> In 2022, it was the 87th most commonly prescribed medication in the United States, with more than 7{{nbsp}}million prescriptions.<ref>{{cite web | title=The Top 300 of 2022 | url=https://clincalc.com/DrugStats/Top300Drugs.aspx | website=ClinCalc | access-date=30 August 2024 | archive-date=30 August 2024 | archive-url=https://web.archive.org/web/20240830202410/https://clincalc.com/DrugStats/Top300Drugs.aspx | url-status=live }}</ref><ref>{{cite web | title = Amitriptyline Drug Usage Statistics, United States, 2013 - 2022 | website = ClinCalc | url = https://clincalc.com/DrugStats/Drugs/Amitriptyline | access-date = 30 August 2024 | archive-date = 30 April 2017 | archive-url = https://web.archive.org/web/20170430155658/https://clincalc.com/DrugStats/Drugs/Amitriptyline | url-status = live }}</ref> {{TOC limit}}
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)